Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Cheryl Rosenfeld, DO, North Jersey Endocrine Consultants, LLC
ClinicalTrials.gov Identifier:
NCT01137695
First received: June 3, 2010
Last updated: October 13, 2011
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2012
  Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)